section name header

Basics ⬇

DESCRIPTION

EPIDEMIOLOGY

Rare congenital heart lesion, occurs equally in male and female patients.

Incidence

5/100,000 live births

Prevalence

~0.5% of all cases of congenital heart disease

RISK FACTORS

Association with maternal lithium therapy:

Genetics

GENERAL PREVENTION

See above regarding maternal lithium exposure and risk of EA.

PATHOPHYSIOLOGY

Large RA with atrialized RV inflow and significant tricuspid insufficiency. Most often is associated with right-to-left shunting across a patent foramen ovale (PFO) or ASD and decreased RV filling. The small and sometimes dysfunctional RV, with or without pulmonary stenosis, also contributes to symptoms of low cardiac output.

ETIOLOGY

The etiology has not been established in most cases of EA.

COMMONLY ASSOCIATED CONDITIONS

Diagnosis ⬆ ⬇

Signs and symptoms:

History

Physical Exam

DIAGNOSTIC TESTS & INTERPRETATION

Lab

Imaging

Diagnostic Procedures/Surgery

Cardiac catheterization is not necessary solely for diagnosis, and has been associated with increased risk.

DIFFERENTIAL DIAGNOSIS

Medication (Drugs) ⬆ ⬇

Treatment ⬆ ⬇

ADDITIONAL TREATMENT

General Measures

SURGERY

Indications for surgical intervention not clearly established:

Ongoing Care ⬆ ⬇

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

Pregnancy Considerations

Pregnancy in asymptomatic women with EA is generally well tolerated. Risk of fetal miscarriage, premature delivery, and low birth weight are increased with maternal cyanosis.

PATIENT EDUCATION

PROGNOSIS

Miscellaneous ⬆ ⬇

CODES

ICD9

746.2 Ebstein anomaly

SNOMED

Reference(s) ⬆ ⬇

ADDITIONAL READING

Author(s) ⬆

Beth Feller Printz

Welton M. Gersony